EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

A Cross-Sectional Study of Rift Valley Fever Exposure in Humans and Livestock in Southwestern Uganda Using a One Health Approach: Evidence of Elevated Seroprevalence Outside Recognized Outbreak Periods

Luke Nyakarahuka, Silvia Situma iD, Raymond Odinoh, Barnabas Bakamutumaho, Carolyne Nasimiyu iD, Jeanette Dawa, Justine Okello iD, Honest Kemiyondo, Alex Tumusiime, Mutesi Joanita, Jackson Kyondo, John Kayiwa iD und 4 weitere

Pathogens · 2026

DOI: 10.3390/pathogens15020224 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Pathogens, 2026. Verfasst von Luke Nyakarahuka und 15 weiteren Autor:innen. Beteiligte Einrichtung: Uganda Virus Research Institute, Entebbe P.O. Box 49, Uganda. Hauptthemen laut MEDLINE: Rift Valley Fever, Livestock, Rift Valley fever virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), through the Centre for Research in Emerging Infectious D…, U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rift Valley fever (RVF) transmission has intensified in southwestern Uganda since 2016. To quantify human and livestock exposure and associated risks, we conducted a cross-sectional serosurvey in Isingiro, Kabale and Rubanda districts between October and November 2023. A total of 766 humans and 2383 livestock were sampled and tested for RVF antibodies using ELISA, with structured questionnaires capturing demographic, behavioral and environmental data. Human seroprevalence was 11.5% (88/766), varying by district (13.8% Isingiro, 11.8% Rubanda, 6.8% Kabale; p = 0.04). Independent predictors from the multivariate model included raw-meat consumption (aOR 6.11; 95% CI 1.16–27.80), cattle ownership (aOR 2.33; 95% CI 1.27–4.36), male sex (aOR 1.64; 95% CI 1.02–2.66) and younger age compared with ≥50 years (31–49 years: aOR 2.02; 95% CI 1.20–3.48; 18–30 years: aOR 2.37; 95% CI 1.04–5.14). Herd-level seroprevalence was 42.5% (204/480), associated with cattle presence (aOR 6.48; 95% CI 4.10–10.40), lack of carcass burial (aOR 15.70; 95% CI 4.23–63.60), on-farm slaughter (aOR 2.14; 95% CI 1.21–3.89) and increased mosquito activity (aOR 1.75; 95% CI 1.13–2.73). Animal-level seroprevalence was 14.6% (347/2383), highest in cattle (33.8%), with cattle having markedly higher odds than goats (aOR 6.73; 95% CI 4.96–9.14). These findings demonstrate substantial transmission and highlight cattle-centered interfaces as primary targets for control to humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rift Valley FeverLivestockRift Valley fever virusAnimalsHumansSeroepidemiologic StudiesCross-Sectional StudiesUgandaMaleFemaleAdultCattleMiddle AgedAdolescentYoung AdultAntibodies, ViralRisk FactorsDisease OutbreaksChildGoatsChild, Preschool

Stichwörter der Autor:innen

Ugandacattleepidemiologylivestockone healthrift valley feverrisk factorsseroprevalencevector-borne diseaseszoonotic diseases

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Uganda Virus Research Institute, Entebbe P.O. Box 49, Uganda.
  • Rollins School of Public Health, Emory University, 1518 Clifton Rd NE., Atlanta, GA 30322, USA.
  • Department of Biosecurity, Ecosystems and Veterinary Public Health, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala P.O. Box 7062, Uganda.
  • Center for Research in Emerging Infectious Diseases East and Central Africa, Nairobi 00202, Kenya.
  • Department of Animal Science, Pwani University, Kilifi 80108, Kenya.
  • Washington State University Global Health Program-Kenya, Nairobi 00200, Kenya.

ORCID-Profile: Silvia Situma, Carolyne Nasimiyu, Justine Okello, John Kayiwa, Robert F Breiman

Förderung

  • U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID/NIH), through the Centre for Research in Emerging Infectious D…
  • U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health

Zitieren

APA

Nyakarahuka, L., Situma, S., Odinoh, R., Bakamutumaho, B., Nasimiyu, C., Dawa, J., Okello, J., Kemiyondo, H., Tumusiime, A., Joanita, M., Kyondo, J., Kayiwa, J., Odongo, D., Ndumu, D. B., Njenga, K. M., & Breiman, R. F. (2026). A Cross-Sectional Study of Rift Valley Fever Exposure in Humans and Livestock in Southwestern Uganda Using a One Health Approach: Evidence of Elevated Seroprevalence Outside Recognized Outbreak Periods. Pathogens. https://doi.org/10.3390/pathogens15020224

Vancouver

Nyakarahuka L, Situma S, Odinoh R, Bakamutumaho B, Nasimiyu C, Dawa J, et al. A Cross-Sectional Study of Rift Valley Fever Exposure in Humans and Livestock in Southwestern Uganda Using a One Health Approach: Evidence of Elevated Seroprevalence Outside Recognized Outbreak Periods. Pathogens. 2026. doi:10.3390/pathogens15020224

BibTeX
@article{Nyakarahuka2026,
  author = {Nyakarahuka, Luke and Situma, Silvia and Odinoh, Raymond and Bakamutumaho, Barnabas and Nasimiyu, Carolyne and Dawa, Jeanette and Okello, Justine and Kemiyondo, Honest and Tumusiime, Alex and Joanita, Mutesi and Kyondo, Jackson and Kayiwa, John and Odongo, David and Ndumu, Deo Birungi and Njenga, Kariuki M and Breiman, Robert F},
  title = {A Cross-Sectional Study of Rift Valley Fever Exposure in Humans and Livestock in Southwestern Uganda Using a One Health Approach: Evidence of Elevated Seroprevalence Outside Recognized Outbreak Periods},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15020224}
}
Kostenlos starten →